{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T22:40:31Z","timestamp":1795128031100,"version":"4.10.3"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T00:00:00Z","timestamp":1704931200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81971428"],"award-info":[{"award-number":["81971428"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81971433"],"award-info":[{"award-number":["81971433"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271749"],"award-info":[{"award-number":["82271749"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82371717"],"award-info":[{"award-number":["82371717"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.biopha.2024.116157","type":"journal-article","created":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T17:25:11Z","timestamp":1706808311000},"page":"116157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Diagnostic and therapeutic potentials of methyltransferase-like 3 in liver diseases"],"prefix":"10.1016","volume":"172","author":[{"given":"Xiaojuan","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruifeng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2599-7041","authenticated-orcid":false,"given":"Dezhi","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2024.116157_bib1","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/978-3-031-05843-1_16","article-title":"Comparative and evolutionary aspects of the digestive system and its enteric nervous system control","volume":"1383","author":"Furness","year":"2022","journal-title":"Adv. Exp. Med. Biol."},{"issue":"7955","key":"10.1016\/j.biopha.2024.116157_bib2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41586-023-05829-8","article-title":"Gut enterochromaffin cells drive visceral pain and anxiety","volume":"616","author":"Bayrer","year":"2023","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.biopha.2024.116157_bib3","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S2468-1253(19)30412-1","article-title":"The effect of sleep on gastrointestinal functioning in common digestive diseases","volume":"5","author":"Orr","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"8","key":"10.1016\/j.biopha.2024.116157_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/biom12081158","article-title":"Research progress on the role of RNA m6A modification in glial cells in the regulation of neurological diseases","volume":"12","author":"You","year":"2022","journal-title":"Biomolecules"},{"issue":"4","key":"10.1016\/j.biopha.2024.116157_bib5","doi-asserted-by":"crossref","first-page":"664","DOI":"10.3390\/biom13040664","article-title":"The regulatory network of METTL3 in the nervous system: diagnostic biomarkers and therapeutic targets","volume":"13","author":"Su","year":"2023","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/j.biopha.2024.116157_bib6","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jhep.2022.09.020","article-title":"Mitochondrial alterations in fatty liver diseases","volume":"78","author":"Fromenty","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2024.116157_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101238","article-title":"Metabolic-associated fatty liver disease and lipoprotein metabolism","volume":"50","author":"Heeren","year":"2021","journal-title":"Mol. Metab."},{"issue":"1","key":"10.1016\/j.biopha.2024.116157_bib8","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/lipd.12023","article-title":"Curcumin attenuates lipopolysaccharide-induced hepatic lipid metabolism disorder by modification of m(6) A RNA methylation in piglets","volume":"53","author":"Lu","year":"2018","journal-title":"Lipids"},{"issue":"7","key":"10.1016\/j.biopha.2024.116157_bib9","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1016\/j.celrep.2018.10.068","article-title":"Circadian clock regulation of hepatic lipid metabolism by modulation of m(6)A mRNA methylation","volume":"25","author":"Zhong","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.biopha.2024.116157_bib10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.mam.2018.09.002","article-title":"Liver fibrosis: pathophysiology, pathogenetic targets and clinical issues","volume":"65","author":"Parola","year":"2019","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.biopha.2024.116157_bib11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.addr.2017.05.007","article-title":"Hepatic stellate cells as key target in liver fibrosis","volume":"121","author":"Higashi","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"4","key":"10.1016\/j.biopha.2024.116157_bib12","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.bbrc.2015.11.029","article-title":"Effect of acid-sensing ion channel 1a on the process of liver fibrosis under hyperglycemia","volume":"468","author":"Wang","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"11","key":"10.1016\/j.biopha.2024.116157_bib13","doi-asserted-by":"crossref","first-page":"14371","DOI":"10.1096\/fj.202001337R","article-title":"ASIC1a regulates miR-350\/SPRY2 by N(6) -methyladenosine to promote liver fibrosis","volume":"34","author":"Zhu","year":"2020","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.biopha.2024.116157_bib14","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cgh.2021.11.014","article-title":"Outcomes of nonalcoholic steatohepatitis after liver transplantation: an updated meta-analysis and systematic review","volume":"21","author":"Yong","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.biopha.2024.116157_bib15","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/hep.30251","article-title":"Global perspectives on nonalcoholic fatty liver disease and nonalcoholic Steatohepatitis","volume":"69","author":"Younossi","year":"2019","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.biopha.2024.116157_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-27539-3","article-title":"The methyltransferase METTL3 negatively regulates nonalcoholic steatohepatitis (NASH) progression","volume":"12","author":"Li","year":"2021","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.biopha.2024.116157_bib17","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.jcmgh.2021.05.007","article-title":"METTL3\/METTL14 transactivation and m(6)A-dependent TGF-beta1 translation in activated Kupffer cells","volume":"12","author":"Feng","year":"2021","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"issue":"10360","key":"10.1016\/j.biopha.2024.116157_bib18","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","article-title":"Hepatocellular carcinoma","volume":"400","author":"Vogel","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2024.116157_bib19","article-title":"Contributions and prognostic values of N6-methyladenosine RNA methylation regulators in hepatocellular carcinoma","volume":"11","author":"Qi","year":"2020","journal-title":"Front. Genet."},{"key":"10.1016\/j.biopha.2024.116157_bib20","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.2147\/CMAR.S191565","article-title":"Expression profiles and prognostic significance of RNA N6-methyladenosine-related genes in patients with hepatocellular carcinoma: evidence from independent datasets","volume":"11","author":"Zhou","year":"2019","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.biopha.2024.116157_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.822011","article-title":"Diagnostic, therapeutic, and prognostic value of the m(6)A writer complex in hepatocellular carcinoma","volume":"10","author":"Gu","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"issue":"4","key":"10.1016\/j.biopha.2024.116157_bib22","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1007\/s10620-020-06260-z","article-title":"Identification of METTL3 as an adverse prognostic biomarker in hepatocellular carcinoma","volume":"66","author":"Liu","year":"2021","journal-title":"Dig. Dis. Sci."},{"issue":"Pt 3","key":"10.1016\/j.biopha.2024.116157_bib23","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.semcancer.2021.07.017","article-title":"Epigenetics in hepatocellular carcinoma","volume":"86","author":"Nagaraju","year":"2022","journal-title":"Semin Cancer Biol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116157_bib24","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-020-1136-6","article-title":"m6A mRNA methylation regulates CTNNB1 to promote the proliferation of hepatoblastoma (vol 18, 188, 2019)","volume":"19","author":"Liu","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biopha.2024.116157_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.578816","article-title":"IGF2BP2 promotes liver cancer growth through an m6A-FEN1-dependent mechanism","volume":"10","author":"Pu","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biopha.2024.116157_bib26","doi-asserted-by":"crossref","unstructured":"Chen, M., et al., RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2. Hepatology, 2018. 67(6): p. 2254\u20132270. doi: 10.1002 \/hep.29683.","DOI":"10.1002\/hep.29683"},{"issue":"12","key":"10.1016\/j.biopha.2024.116157_bib27","first-page":"13423","article-title":"METTL3 facilitates the progression of hepatocellular carcinoma by modulating the m6A level of USP7","volume":"13","author":"Li","year":"2021","journal-title":"Am. J. Transl. Res"},{"issue":"9","key":"10.1016\/j.biopha.2024.116157_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.23931","article-title":"METTL3-mediated m6A methylation of ASPM drives hepatocellular carcinoma cells growth and metastasis","volume":"35","author":"Wang","year":"2021","journal-title":"J. Clin. Lab. Anal."},{"issue":"8","key":"10.1016\/j.biopha.2024.116157_bib29","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1002\/cam4.2918","article-title":"METTL3 expression is associated with glycolysis metabolism and sensitivity to glycolytic stress in hepatocellular carcinoma","volume":"9","author":"Lin","year":"2020","journal-title":"Cancer Med."},{"key":"10.1016\/j.biopha.2024.116157_bib30","doi-asserted-by":"crossref","unstructured":"Qiao, K.L., et al., RNA m6A methylation promotes the formation of vasculogenic mimicry in hepatocellular carcinoma via Hippo pathway (vol 24, pg 83, 2021). Angiogenesis, 2023. 26(1), 197\u2013199. doi: 10.1007\/s10456\u2013020 -09744\u20138.","DOI":"10.1007\/s10456-022-09857-2"},{"key":"10.1016\/j.biopha.2024.116157_bib31","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/7529164","article-title":"Pinin induces epithelial-to-mesenchymal transition in hepatocellular carcinoma by regulating m6A modification","volume":"2021","author":"Qiao","year":"2021","journal-title":"J. Oncol."},{"key":"10.1016\/j.biopha.2024.116157_bib32","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.bbrc.2021.01.085","article-title":"METTL3\/IGF2BP1\/CD47 contributes to the sublethal heat treatment induced mesenchymal transition in HCC","volume":"546","author":"Fan","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2024.116157_bib33","doi-asserted-by":"crossref","unstructured":"Xu, H.F., et al., SUMO1 modification of methyltransferase-like 3 promotes tumor progression via regulating Snail mRNA homeostasis in hepatocellular carcinoma. Theranostics, 2020. 10(13, 5671\u20135686. doi:10.7150\/thno. 42539.","DOI":"10.7150\/thno.42539"},{"issue":"3","key":"10.1016\/j.biopha.2024.116157_bib34","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12768","article-title":"Cross talk between RNA N6-methyladenosine methyltransferase-like 3 and miR-186 regulates hepatoblastoma progression through Wnt\/beta-catenin signalling pathway.","volume":"53","author":"Cui","year":"2020","journal-title":"Cell Prolif."},{"issue":"5","key":"10.1016\/j.biopha.2024.116157_bib35","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1111\/jcmm.15030","article-title":"miR24-2 accelerates progression of liver cancer cells by activating Pim1 through tri-methylation of Histone H3 on the ninth lysine","volume":"24","author":"Yang","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.biopha.2024.116157_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.762588","article-title":"Methyltransferase-Like 3-mediated m6A methylation of Hsa_circ_0058493 accelerates hepatocellular carcinoma progression by binding to YTH domain-containing protein 1","volume":"9","author":"Wu","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"4","key":"10.1016\/j.biopha.2024.116157_bib37","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.hbpd.2022.08.005","article-title":"Hypermethylation of thymosin \u03b24 predicts a poor prognosis for patients with acute-on-chronic hepatitis B liver failure","volume":"22","author":"Wang","year":"2023","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"issue":"2","key":"10.1016\/j.biopha.2024.116157_bib38","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/iub.2438","article-title":"N-6-methyladenosine modification of circular RNA circ-ARL3 facilitates Hepatitis B virus-associated hepatocellular carcinoma via sponging miR-1305","volume":"73","author":"Rao","year":"2021","journal-title":"IUBMB Life"},{"key":"10.1016\/j.biopha.2024.116157_bib39","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.omtn.2021.09.001","article-title":"m6A modification of circHPS5 and hepatocellular carcinoma progression through HMGA2 expression","volume":"26","author":"Rong","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"1","key":"10.1016\/j.biopha.2024.116157_bib40","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1080\/21655979.2021.2017579","article-title":"Has_circ_0008583 modulates hepatocellular carcinoma progression through the miR-1301-3p\/METTL3 pathway","volume":"13","author":"Wang","year":"2022","journal-title":"Bioengineered"},{"issue":"1","key":"10.1016\/j.biopha.2024.116157_bib41","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-019-0839-x","article-title":"m6A-mediated upregulation of LINC00958 increases lipogenesis and acts as a nanotherapeutic target in hepatocellular carcinoma.","volume":"13","author":"Zuo","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.biopha.2024.116157_bib42","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.2147\/OTT.S289198","article-title":"m6A-induced LncRNA MEG3 suppresses the proliferation, migration and invasion of hepatocellular carcinoma cell through miR-544b\/BTG2 signaling","volume":"14","author":"Wu","year":"2021","journal-title":"Oncotargets Ther."},{"key":"10.1016\/j.biopha.2024.116157_bib43","doi-asserted-by":"crossref","unstructured":"Chen, Y.T., et al., Upregulation of lncRNA NIFK-AS1 in hepatocellular carcinoma by m(6)A methylation promotes disease progression and sorafenib resistance. Hum Cell, 2021. 34(6), 1800\u20131811. doi: 10.1007\/s13577\u2013021- 00587-z.","DOI":"10.1007\/s13577-021-00587-z"},{"issue":"1","key":"10.1016\/j.biopha.2024.116157_bib44","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/15592294.2020.1788324","article-title":"Fusaric acid decreases p53 expression by altering promoter methylation and m6A RNA methylation in human hepatocellular carcinoma (HepG2) cells","volume":"16","author":"Ghazi","year":"2021","journal-title":"Epigenetics"},{"issue":"1","key":"10.1016\/j.biopha.2024.116157_bib45","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-09865-9","article-title":"RNA m(6)A methylation regulates the epithelial mesenchymal transition of cancer cells and translation of Snail","volume":"10","author":"Lin","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2024.116157_bib46","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.omtn.2020.11.009","article-title":"CircMEG3 inhibits telomerase activity by reducing Cbf5 in human liver cancer stem cells","volume":"23","author":"Jiang","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"12","key":"10.1016\/j.biopha.2024.116157_bib47","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2019103181","article-title":"RNA m(6) A methylation regulates sorafenib resistance in liver cancer through FOXO3-mediated autophagy","volume":"39","author":"Lin","year":"2020","journal-title":"EMBO J."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224000386?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224000386?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T13:41:21Z","timestamp":1760103681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224000386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":47,"alternative-id":["S0753332224000386"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116157","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic and therapeutic potentials of methyltransferase-like 3 in liver diseases","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116157","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116157"}}